Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Merck Unites With Schering Plough But India Goes Slow On Integration; Operational Structure And Merger Issues Remain Foggy

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - It may have been a mega integration of operations of the two New Jersey-headquartered companies - Merck and Schering Plough - but it stays status quo in India and the affiliates of the two large companies will continue to operate independently till the final contours emerge "in the next few months.

You may also be interested in...

With More Vaccines For Low-Income Countries In Mind, Merck Signs JV With Wellcome Trust; India To Be Research And Manufacturing Hub

MUMBAI - New opportunities like preventive vaccines for developing countries are throwing up newer alliances between disparate stakeholders. In one such deal, New Jersey-headquartered Merck has formed a first-of-its-kind equal stake collaboration with Wellcome Trust of the United Kingdom to work on research and development of vaccines that can prevent diseases mainly in low-income countries

With Schering-Plough, Merck Will Have Better Reach And Larger Product Basket In India

MUMBAI - After a long spell of near-dormancy, in Dec. 2006, Schering-Plough's India unit roped in K.G. Ananthakrishnan from Pfizer India to head its fledgling arm with a mandate to revive the company

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts